RÉSUMÉ
Human neural progenitor cells provide a source for cell replacement therapy to treat neurodegenerative diseases. Therefore, there is great interest in mechanisms and tools to direct the fate of multipotent progenitor cells during their differentiation to increase the yield of a desired cell type. We tested small molecule inhibitors of glycogen synthase kinase-3 (GSK-3) for their functionality and their influence on neurogenesis using the human neural progenitor cell line ReNcell VM. Here we report the enhancement of neurogenesis of human neural progenitor cells by treatment with GSK-3 inhibitors. We tested different small molecule inhibitors of GSK-3 i.e. LiCl, sodium-valproate, kenpaullone, indirubin-3-monoxime and SB-216763 for their ability to inhibit GSK-3 in human neural progenitor cells. The highest in situ GSK-3 inhibitory effect of the drugs was found for kenpaullone and SB-216763. Accordingly, kenpaullone and SB-216763 were the only drugs tested in this study to stimulate the Wnt/ß-catenin pathway that is antagonized by GSK-3. Analysis of human neural progenitor differentiation revealed an augmentation of neurogenesis by SB-216763 and kenpaullone, without changing cell cycle exit or cell survival. Small molecule inhibitors of GSK-3 enhance neurogenesis of human neural progenitor cells and may be used to direct the differentiation of neural stem and progenitor cells in therapeutic applications.
Sujet(s)
Antienzymes/pharmacologie , Glycogen Synthase Kinase 3/antagonistes et inhibiteurs , Glycogen Synthase Kinase 3/métabolisme , Cellules souches neurales/effets des médicaments et des substances chimiques , Neurogenèse/effets des médicaments et des substances chimiques , Mort cellulaire/effets des médicaments et des substances chimiques , Différenciation cellulaire/effets des médicaments et des substances chimiques , Lignée de cellules transformées , Relation dose-effet des médicaments , Cytométrie en flux/méthodes , Régulation de l'expression des gènes codant pour des enzymes/effets des médicaments et des substances chimiques , Humains , Méthode TUNEL/méthodes , Phosphorylation/effets des médicaments et des substances chimiques , Statistique non paramétrique , Facteurs tempsRÉSUMÉ
BACKGROUND: Hypoxia plays a critical role in various cellular mechanisms, including proliferation and differentiation of neural stem and progenitor cells. In the present study, we explored the impact of lowered oxygen on the differentiation potential of human neural progenitor cells, and the role of erythropoietin in the differentiation process. RESULTS: In this study we demonstrate that differentiation of human fetal neural progenitor cells under hypoxic conditions results in an increased neurogenesis. In addition, expansion and proliferation under lowered oxygen conditions also increased neuronal differentiation, although proliferation rates were not altered compared to normoxic conditions. Erythropoietin partially mimicked these hypoxic effects, as shown by an increase of the metabolic activity during differentiation and protection of differentiated cells from apoptosis. CONCLUSION: These results provide evidence that hypoxia promotes the differentiation of human fetal neural progenitor cells, and identifies the involvement of erythropoietin during differentiation as well as different cellular mechanisms underlying the induction of differentiation mediated by lowered oxygen levels.
Sujet(s)
Érythropoïétine/pharmacologie , Cellules souches neurales/cytologie , Neurones/cytologie , Apoptose , Différenciation cellulaire , Hypoxie cellulaire , Prolifération cellulaire , Humains , Sous-unité alpha du facteur-1 induit par l'hypoxie/métabolisme , Cellules souches neurales/effets des médicaments et des substances chimiques , Cellules souches neurales/métabolisme , Oxygène/pharmacologie , Récepteur érythropoïétine/métabolismeRÉSUMÉ
BACKGROUND: 3D-scaffolds have been shown to direct cell growth and differentiation in many different cell types, with the formation and functionalisation of the 3D-microenviroment being important in determining the fate of the embedded cells. Here we used a hydrogel-based scaffold to investigate the influences of matrix concentration and functionalisation with laminin on the formation of the scaffolds, and the effect of these scaffolds on human neural progenitor cells cultured within them. METHODS: In this study we used different concentrations of the hydrogel-based matrix PuraMatrix. In some experiments we functionalised the matrix with laminin I. The impact of concentration and treatment with laminin on the formation of the scaffold was examined with atomic force microscopy. Cells from a human fetal neural progenitor cell line were cultured in the different matrices, as well as in a 2D culture system, and were subsequently analysed with antibody stainings against neuronal markers. In parallel, the survival rate of the cells was determined by a live/dead assay. RESULTS: Atomic force microscopy measurements demonstrated that the matrices are formed by networks of isolated PuraMatrix fibres and aggregates of fibres. An increase of the hydrogel concentration led to a decrease in the mesh size of the scaffolds and functionalisation with laminin promoted aggregation of the fibres (bundle formation), which further reduces the density of isolated fibres. We showed that laminin-functionalisation is essential for human neural progenitor cells to build up 3D-growth patterns, and that proliferation of the cells is also affected by the concentration of matrix. In addition we found that 3D-cultures enhanced neuronal differentiation and the survival rate of the cells compared to 2D-cultures. CONCLUSIONS: Taken together, we have demonstrated a direct influence of the 3D-scaffold formation on the survival and neuronal differentiation of human neural progenitor cells. These findings emphasize the importance of optimizing 3D-scaffolds protocols prior to in vivo engraftment of stem and progenitor cells in the context of regenerative medicine.
Sujet(s)
Différenciation cellulaire/effets des médicaments et des substances chimiques , Cellules souches neurales/cytologie , Cellules souches neurales/effets des médicaments et des substances chimiques , Structures d'échafaudage tissulaires/composition chimique , Techniques de culture cellulaire , Survie cellulaire/effets des médicaments et des substances chimiques , Humains , Hydrogels/composition chimique , Hydrogels/pharmacologie , Laminine/composition chimique , Neurones/cytologie , Ingénierie tissulaireRÉSUMÉ
The Wnt pathway is involved in cellular processes linked to either proliferation or differentiation. Therefore small molecules offer an attractive opportunity to modulate this pathway, whereas the key enzyme GSK-3beta is of special interest. In this study, non-symmetrically substituted indolylmaleimides have been synthesized and their ability to function as GSK-3beta inhibitors has been investigated in a human neural progenitor cell line. Among the newly synthesized compounds, the substance IM-12 showed a significant activity in several biological tests which was comparable or even outplayed the effects of the known GSK-3beta inhibitor SB-216763. Furthermore the treatment of human neural progenitor cells with IM-12 resulted in an increase of neuronal cells. Therefore we conclude that indolylmaleimides act via the canonical Wnt signalling pathway by inhibition of the key enzyme GSK-3beta.
Sujet(s)
Glycogen Synthase Kinase 3/antagonistes et inhibiteurs , Indoles/composition chimique , Maléimides/composition chimique , Neurones/cytologie , Inhibiteurs de protéines kinases/composition chimique , Cellules souches/enzymologie , Différenciation cellulaire , Prolifération cellulaire , Glycogen Synthase Kinase 3/métabolisme , Glycogen synthase kinase 3 beta , Humains , Indoles/synthèse chimique , Indoles/pharmacologie , Maléimides/synthèse chimique , Maléimides/pharmacologie , Inhibiteurs de protéines kinases/synthèse chimique , Inhibiteurs de protéines kinases/pharmacologie , Transduction du signal , Cellules souches/cytologie , Protéines de type Wingless/métabolisme , bêta-Caténine/métabolismeRÉSUMÉ
3-Amidoindoles were synthesized from commercially available arylhydrazines and propargylamines over Zn-salt mediated one pot procedure in excellent regioselectivity and up to 94% yield.
Sujet(s)
Glycogen Synthase Kinase 3/antagonistes et inhibiteurs , Glycogen Synthase Kinase 3/métabolisme , Indoles/pharmacologie , Lignée cellulaire , Glycogen synthase kinase 3 beta , Humains , Indoles/synthèse chimique , Structure moléculaire , bêta-Caténine/métabolismeRÉSUMÉ
The survival of developing dopaminergic neurons has been shown to be modulated by voltage-dependent mechanisms. Manipulation of these mechanisms in human neural progenitor cell cultures could improve the survival of immature dopaminergic neurons, and therefore aid research into pharmacological and cell replacement therapies for Parkinson's disease. Here, we examined the effect of the Na+ channel agonist veratridine on the human fetal neural progenitor ReNcell VM cell line. Neuronal differentiation was determined by immunocytochemistry, whereas patch clamp recordings showed the expression of functional voltage-gated sodium channels. Our results show that veratridine is neuroprotective in human fetal neural progenitor cells, which may benefit studies investigating neuronal development by reducing premature death amongst developing neurons.
Sujet(s)
Neurones/effets des médicaments et des substances chimiques , Neuroprotecteurs/pharmacologie , Cellules souches/effets des médicaments et des substances chimiques , Vératridine/pharmacologie , Numération cellulaire , Mort cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire , Survie cellulaire/effets des médicaments et des substances chimiques , Humains , Immunohistochimie , Potentiels de membrane/effets des médicaments et des substances chimiques , Neurogenèse/effets des médicaments et des substances chimiques , Neurones/physiologie , Techniques de patch-clamp , Canaux potassiques voltage-dépendants/métabolisme , Agonistes de canaux sodiques , Bloqueurs de canaux sodiques/pharmacologie , Canaux sodiques/métabolisme , Cellules souches/physiologie , Tétrodotoxine/pharmacologie , Facteurs temps , Tyrosine 3-monooxygenase/métabolismeRÉSUMÉ
Improved palladium catalysts for the Suzuki coupling of 3-bromo-1-methyl-4-(2-methyl-3-indolyl)maleimide have been developed. The coupling of both aryl- and heteroarylboronic acids proceeds smoothly in good to excellent yields at low catalyst loading.
Sujet(s)
Indoles/synthèse chimique , Maléimides/synthèse chimique , Palladium/composition chimique , Composés du bore/composition chimique , Catalyse , Indoles/composition chimique , Maléimides/composition chimique , Structure moléculaire , Composés organiques du phosphore/composition chimiqueRÉSUMÉ
Several orphan G-protein-coupled receptors (GPCRs), LGR7 and LGR8, GPCR135 and GPCR142, were recently identified as putative, native receptors for different relaxin-family peptides, and their cell signaling mechanisms were elucidated in stably transfected cell lines. Anatomic studies have demonstrated that discrete populations of neurons in rat brain express relaxin and relaxin-3 mRNA/peptide, relaxin and relaxin-3 binding sites, and LGR7 and GPCR135 mRNAs. Thus, we began to assess the ability of relaxin-family peptides to alter cAMP production in brain and the involvement of the different native receptors. In mouse cortical membranes, a fixed concentration of relaxin peptides (100 nM) inhibited forskolin-induced cAMP production, but further studies in normal and receptor knockout mouse strains are required to assess the specificity of these effects. In addition, whole-cell signaling mechanisms are being investigated in a mouse hypothalamic cell line, GT1-7. Such studies will help to establish the actions of relaxin-family peptides via their different GPCRs in different brain pathways.
Sujet(s)
Encéphale/métabolisme , Insuline/métabolisme , Membranes/métabolisme , Neurones/métabolisme , Récepteur à l'insuline/métabolisme , Récepteurs peptidiques/métabolisme , Relaxine/métabolisme , Animaux , Encéphale/cytologie , Lignée cellulaire , AMP cyclique/biosynthèse , Humains , Insuline/classification , Membranes/effets des médicaments et des substances chimiques , Souris , Souris de lignée C57BL , Liaison aux protéines , Rats , Récepteurs couplés aux protéines G , Relaxine/classification , Relaxine/pharmacologie , Transduction du signal/effets des médicaments et des substances chimiquesRÉSUMÉ
We investigated the potential of ATP to inhibit heterologously expressed NMDA receptor subunit combinations, NMDA-induced currents in cultured hippocampal cells, and NMDA-induced neurotoxicity. The effect of ATP on diheteromeric NR1a/NR2A-D NMDA receptor (NR) combinations expressed in Xenopus laevis oocytes was studied by voltage-clamp recording. ATP strongly inhibited NMDA-induced inward currents only at the NR1a/NR2B receptor combination. At NMDA concentrations corresponding to the EC50 value (20 microm), ATP revealed an IC50 value of 135 microm. Mutation studies suggest that ATP exerts its inhibition via the glutamate-binding pocket of the NR2B subunit. Inosine 5'-triphosphate (ITP), GTP, and AMP also inhibited the recombinant NR1a/NR2B receptor, whereas UTP and CTP, ADP, or adenosine had no or only a small effect. Correspondingly, ATP inhibited NMDA-induced but not kainate-induced currents at cultured hippocampal neurons. An abundant expression of the NR2B subunit in the cultured neurons was verified by immunocytochemistry and blockade of NMDA-induced currents by the NR2B-selective antagonist ifenprodil. In addition we studied the role of ATP in NMDA-mediated neurotoxicity using cultured rat hippocampal cells. ATP exhibited a dose-dependent rescue effect when coapplied with the excitotoxicant NMDA, in contrast to ADP, AMP, and adenosine. The effect of ATP was mimicked by GTP and ITP but not by UTP and CTP. ATP had no effect on kainate-elicited neurotoxicity. Our results suggest that ATP can act as an inhibitor of NMDA receptors depending on receptor subunit composition and that it can attenuate NMDA-mediated neurotoxicity that is mediated neither by ATP nor by adenosine receptors.